Infliximab

• Description:

  Infliximab is a humanized antibody against tumor necrosis factor α TNF-α) that is used in the treatment of Crohn's disease and rheumatoid arthritis.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  149 kDa

• Molecular Formula:

  ——

• Notes:

  Research use only, not for human use.

• Receptor:

  TNF

• CAS Number:

  170277-31-3